Scientists are looking for answers about how these confounding trips, known as metastases, occur throughout the human body ...

Learn about how different healthcare providers work together to help breast cancer patients weigh their treatment options.

First-line Rybrevant plus Lazcluze significantly extended overall survival versus Tagrisso in mutated, advanced or metastatic non-small cell lung cancer.

The FDA has approved Imfinzi® (durvalumab), in combination with gemcitabine and cisplatin, for the treatment of adult patients with MIBC.